PTHS PTHS Contingent liabilities
Contingent liabilities at other companies
Other financials
Where this comes from
Reported directly by PTHS in its filing.
Tagged under the XBRL concept us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent.
The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTHS's contingent liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is PTHS's contingent liabilities?
- PTHS (PTHS) reported contingent liabilities of $1M in Q1 2026.
- What does contingent liabilities mean?
- This represents the estimated fair value of future payments owed to sellers following an acquisition, contingent upon the achievement of specific clinical, regulatory, or commercial milestones. For a clinical-stage biotechnology company, these liabilities often reflect potential payouts tied to successful drug development phases or market approval. Monitoring this balance provides insight into the company's future financial obligations and the risk profile associated with its acquired pipeline assets.